AFLAC INC (AFL): what the price assumes

In the published model solve dated 2026-Q2, anchored at $116.52, AFLAC INC (AFL) is priced for 13.1% return on equity. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. Narrative composed 2026-07-25.

Generated: 2026-08-30 · Source: https://boothcheck.com/report/AFL

Headline

What The Price Assumes (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

Solve inputs: computed at a 8.7% cost of equity with 4% terminal growth over a 10-year stage, on common book equity (FY2026).

How unusual the bet is: within-range

Valuation X-Ray

The price is supported by asset-based and earnings-power value. A value/asset-supported name, not a pure growth bet.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

Families that justify the price: Asset, Earnings

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 8.1%); the inversion above states its own rate.

Per-Model Detail (n=4)

Economic-Unit Decomposition (Sum Of The Parts)

The issuer is a funded financial business. Debt, interest, and cash flows are operating inputs, so industrial EV, net-debt, WACC, and free-cash-flow lenses do not apply; value the common-equity claim with book, earnings, capital, and payout economics.

No unit-level total common-equity value is stated. Each financial unit requires supported standalone common equity, normalized earnings, capital adequacy, and payout capacity. Consolidated debt, interest, and cash are operating balances, not an enterprise-to-equity bridge; company-level book, earnings, capital, and payout lenses remain the coherent cross-checks.

Solvency

Deposit/float-funded balance sheet: debt is funding, not corporate leverage, and GAAP operating cash flow follows loan flows. Net-debt, interest-coverage, and cash-burn lenses do not apply. The solvency frame for a financial is regulatory capital and payout capacity (CET1, stress buffer, dividends plus buybacks against earnings).

Bullet Takeaways

• At roughly 2.1 times book value the market is asking Aflac for about 14.3% on its equity against the 12.4% it has recently produced, and the most visible route to closing that gap runs through the share count rather than through new policies.
• Concentration is the defining fact of the company: Japan supplies the majority of revenue, and the percentage of the Company's total assets attributable to Aflac Japan was 76% at the end of 2025, which puts the yen and Japanese bond yields inside almost every line of the result.
• Second quarter results arrive after the close on August 6, 2026, and the line to read first is Japanese net earned premiums in yen, which fell 3.8% year over year in the first quarter.

Bull Case

The price is asking for something specific and it is worth naming before arguing about it. At roughly 2.1 times book value, the market assumes Aflac sustains a return on equity somewhere near 14.3%. The company has recently been earning about 12.4%. On the face of it that looks like a demand the business is not currently meeting, which is exactly why the arithmetic underneath deserves a closer look, because the gap is smaller than it appears and the company has an unusual tool for closing it.

That tool is the share count. Aflac has retired stock at roughly 5.8% a year over the last four years, which is one of the more aggressive sustained reductions available in any large financial. The 10-K puts 2025's treasury purchases at $3,530 million against $2,800 million in 2024, and 32,994 thousand shares retired under the repurchase program in 2025 against 30,428 thousand the year before. Buying back shares does not make an insurance policy more profitable, but it does shrink the equity base the return is measured against, and it does so mechanically and predictably. A company that keeps writing profitable business while retiring one share in seventeen every year is walking toward a higher return on equity whether or not the underwriting improves.

The underwriting has been improving anyway. The ratio of total benefits and claims to total premiums came in at 59.3 % in 2025 against 62.5 % in 2024, though the company is candid that the move reflected lower benefits resulting from assumption updates in the third quarter of 2025 rather than a change in the shape of the claims themselves. What sits underneath both figures is a product that Japanese and American households buy for a reason the demographics keep reinforcing. Aflac sells supplemental policies that pay cash for the medical and nonmedical costs that are not reimbursed under Japan's national health insurance system, and the 10-K describes the demand mechanism plainly: changes in Japan's economy and an aging population have put increasing pressure on Japan's national health care system. As a result, more costs have been shifted to Japanese consumers. The country's demographics are usually filed under risk. For a supplemental carrier, more of the bill landing on the household is the entire business.

The American side is smaller and sells into a different mechanism. Aflac U.S. distributes through the workplace, where the employer provides the payroll deduction and the sales channel, and where the company says it competes against several supplemental insurance carriers on a national and regional basis. In a cohort where Unum turns over $13.3B of revenue, Globe Life $6.1B, CNO $4.5B and Primerica $3.4B, Aflac's roughly $18.1B combined base gives it distribution reach in supplemental benefits that none of the specialists can match on their own. Trailing net income of $4.64B on that base is what the reader should hold onto: this is a company that converts an unusually large share of what it collects into profit, in a line of insurance where claim severity is capped by the policy design.

Bear Case

The uncomfortable fact under this stock is that its largest business is shrinking. Japan supplies the majority of Aflac's revenue and about three quarters of its assets, and in the first quarter of 2026 Japanese net earned premiums came in at ¥246.7 billion, down 3.8% from a year earlier, with the decline attributed to a new external reinsurance transaction and to limited-pay policies reaching paid-up status. The full year 2025 disclosure tells a version of the same story, with net earned premiums in yen terms lower on roughly ¥21 billion of identified drag. A policy that reaches paid-up status stops generating premium but keeps generating obligation. That is not a crisis and nobody is going to write a headline about it, but it means the core block is being managed toward runoff at the margin while the reported return is held up elsewhere.

Elsewhere is mostly the buyback, and that is where the bear case gets its teeth. Retiring 5.8% of the shares a year raises earnings per share and return on equity without a single additional policy being sold. It is a legitimate use of capital and Aflac has been disciplined about it. It is also finite, it depends on capital continuing to flow from Japan to the parent company, and that flow runs across a currency the company does not control. The 10-K is explicit that the parent utilizes forward contracts as part of its Enterprise Corporate Hedging Program to protect the economic value of Aflac Japan in U.S. dollar terms by hedging foreign currency exchange risk related to dividend payments by Aflac Japan, and equally explicit that this strategy may not be successful. The company's own risk summary lists concentration of business in Japan, limited availability of acceptable Japanese yen-denominated investments and foreign currency fluctuations in the yen/dollar exchange rate in consecutive bullets.

Then there is the accounting texture of the improvement. The benefit ratio dropped by more than three points in 2025, and the filing attributes it to assumption updates in the third quarter of 2025. Assumption updates are a normal and necessary part of long-duration insurance accounting, and they are also the part of the income statement where management judgment has the most room to move a reported number. An improvement sourced from a reserving assumption does not repeat next year the way a rate increase does.

Set that against what the price requires. At about 2.1 times book, the price needs a sustained return on equity near 14.3%, roughly two points above what the business has recently delivered. Historically, only about 62% of firms earning at that level held it for a decade. If the return settles nearer where it is now rather than where the price assumes, the correction comes out of the book multiple, and for an insurer that adjustment is unusually direct: the multiple is essentially a statement about the return, so a lower return means a lower multiple with nothing in between to absorb it.

The counterweight deserves stating, because it is real. Aflac's own record over nearly two decades sits above the return the price is asking for, so this is not a company being asked to do something it has never done. The question is whether a business whose premium base is contracting in its main market can reproduce the returns it earned when that base was growing, and the answer to that is not visible in any of the numbers yet.

Valuation

Two numbers frame this one, and the interesting part is the distance between them. Today's price assumes a sustained return on equity of about 14.3%. What the business has actually been producing sits roughly two points below that. Everything else in the valuation is a question about whether the gap gets closed, and by what.

Insurers make this unusually legible, because the book multiple and the return are the same statement said two ways. Pay 2.1 times the accounting value of the equity and you are asserting the company earns enough above its cost of capital to justify the premium over what the balance sheet says the equity is worth. The calculation rests on a required return of roughly 8.8%, and the sensitivity is worth carrying: every additional percentage point on that required return raises the return the price needs by about 2.1 points. The assumption embedded here is therefore about as exposed to the long end of the bond market as it is to Aflac's claims experience.

The methods used to triangulate the value cluster tightly, which is not the usual pattern for a stock people describe as expensive. The approaches that value the company on current earnings power land above today's price by roughly a tenth. Peer multiples sit about a tenth under it, the asset-value approaches roughly a sixth under, and the forward-looking approach lands almost exactly on it. Nothing here is reaching. This is a price supported by the static methods rather than one that depends on a growth story to be defensible, which is a different animal from most of what trades at a premium to book.

The cohort comparison is awkward in a useful way. Against Unum, Globe Life, CNO, Primerica, MetLife and Prudential Financial, Aflac's price-to-book sits in the upper half of the group. Those peers are supplemental and life carriers with different geographic mixes and different product durations, so the comparison sets a reference rather than settling anything. What it does establish is that the market is not treating Aflac as a discounted runoff story; it is paying a premium relative to the group for a company whose largest premium base has been contracting.

Capital return is where the two numbers finally meet. A share count falling 5.8% a year, funded by $3.53B of treasury purchases in 2025, is the engine that would carry the return the company currently earns up toward what the price assumes, without any help from sales. That is a real mechanism and it has been running for years. It also means the price depends on capital continuing to move from Tokyo to Columbus at an exchange rate nobody at the company sets.

Catalysts

The next dated event is close. Aflac will release second quarter 2026 results after the market closes on Thursday, August 6, 2026, with the management call the following morning. The figure worth finding first in that release is Japanese net earned premiums in yen. Reporting them in dollars mixes the operating result with the exchange rate, and for a company that keeps roughly three quarters of its assets in Japan, that mixture obscures more than it reveals.

The first quarter set the reference points. Net earnings came in at $1.0 billion, or $1.98 per diluted share, against $29 million and $0.05 a year earlier, a swing driven by items below the underwriting line rather than by the policies themselves. Japanese net earned premiums were ¥246.7 billion, 3.8% lower than a year before, with the company attributing the decline to a new external reinsurance transaction covering two product lines and to limited-pay policies reaching paid-up status. Whether that rate of decline steepens or stabilizes is the single most informative thing the August release will contain.

Capital return continued at its established pace, with $1.3 billion sent back to shareholders in the quarter, split between $1.0 billion of repurchases and $315 million of dividends. That cadence, if maintained, keeps the share count shrinking at roughly the rate it has for the past four years, which is the mechanism doing most of the work in the reported return on equity.

Peer Cohorts (Per Segment, With Filing Citations)

Aflac Japan (reported)

• UNM (Unum Group)
• FY2025 10-K: 2019. He previously served as Senior Vice President and President, Closed Block Operations from July 2015 to July 2019 and as Senior Vice President, Chief Risk Officer from August 2013 to July 2015. Ms. Ahmed was named Executive Vice President, People and Communications upon joining the Company in October 2018. She…
• FY2025 10-K: …(FCA). The PRA oversees the financial health and stability of financial services firms and is responsible for the prudential regulation and day-to-day supervision of insurance companies. The FCA seeks to protect consumers and oversees the products and practices of financial services companies in the U.K., including…
• GL (GLOBE LIFE INC.)
• FY2025 10-K: …Globe Life provides a variety of life and supplemental health insurance products to a broad base of customers. The Company is organized into three reportable segments: life insurance, supplemental health insurance, and investments. Globe Life markets its insurance products through a number of distribution channels,…
• FY2025 10-K: …ratio is typically determined by dividing adjusted total statutory capital by the amount of RBC determined using the NAIC's factors. If a company's RBC ratio approaches two times the RBC amount, the company must file a plan with the NAIC for improving its capital levels (this level is commonly referred to as "Company…
• PRI (Primerica, Inc.)
• FY2025 10-K: …Science degree from Georgia State University. She serves on the boards of directors for the Gwinnett Chamber of Commerce and the Community Foundation for Northeast Georgia and on the board of advisors for the Metro Atlanta Chamber of Commerce. Rosie Orlando has served as Executive Vice President of Primerica, Inc.…
• FY2025 10-K: …contestable by the replaced company. We believe this approach helps independent sales representatives sell replacement policies, as it reassures clients that claims made under their replacement policies are not more likely to be contested as to the face amount replaced. Through our claims administration system, we…
• MET (MetLife, Inc.)
• FY2025 10-K: …U.S. dollars or foreign currencies, receives the same short-term credit rating as MLIC or MTL, as applicable, and is marketed by major investment banks' broker-dealer operations. • Funding agreements are issued by certain of our insurance subsidiaries to the Federal Home Loan Bank of New York ("FHLBNY") and to a…
• FY2025 10-K: …insurance liabilities includes disaggregated rollforwards. The products grouped within these rollforwards were selected based upon common characteristics and valuations using similar inputs, judgments, assumptions and methodologies within a particular segment of the business. The adjusted balance in each…
• PRU (PRUDENTIAL FINANCIAL INC)
• FY2025 10-K: …Japan, we voluntarily suspended new sales activity at Prudential of Japan for a 90-day period, commencing February 9, 2026. See "-Litigation and Regulatory Matters-Regulatory" within Note 25 to the Consolidated Financial Statements and "Results of Operations by Segment-International Businesses" below for additional…
• FY2025 10-K: …related to fixed indexed annuities. This agreement was subsequently novated from PALAC to Pruco Life effective October 2021, in connection with the sale of PALAC effective April 2022. Under this reinsurance agreement, which is accounted for under the deposit method of accounting, the Company cedes to Somerset Re its…
• RGA (REINSURANCE GROUP OF AMERICA INC)
• FY2025 10-K: …British pound, Australian dollar, Japanese yen, Korean won, Euro and South African rand. The translation of the functional currency into U.S. dollars is performed for balance sheet accounts using current exchange rates in effect at the balance sheet date and for revenue and expense accounts using weighted average…
• FY2025 10-K: …represented 5.1% and 6.5%, respectively, of total fixed maturity securities. These assets are primarily high quality, long duration provincial strip 72 Table of Contents bonds, the valuation of which is closely linked to the interest rate curve. These assets are longer in duration and held primarily for…
• CNO (CNO Financial Group, Inc.)
• FY2025 10-K: …for agent-sold Medicare supplement insurance products include United HealthCare, Blue Cross and Blue Shield Plans, and Mutual of Omaha. Our main competitors for life insurance sold through direct marketing channels include Mutual of Omaha, Globe Life, Inc., TruStage, AAA Life Insurance, and Gerber Life. Our main…
• FY2025 10-K: …Agents, insurance brokers and marketing companies who market our products and prospective purchasers of our products use the financial strength ratings of our insurance subsidiaries as an important factor in determining whether to market or purchase. Ratings have the biggest impact on our sales of supplemental health…

Aflac U.S. (reported)

• UNM (Unum Group)
• FY2025 10-K: 2019. He previously served as Senior Vice President and President, Closed Block Operations from July 2015 to July 2019 and as Senior Vice President, Chief Risk Officer from August 2013 to July 2015. Ms. Ahmed was named Executive Vice President, People and Communications upon joining the Company in October 2018. She…
• FY2025 10-K: …0000005513 2025 FY FALSE --12-31 http://fasb.org/us-gaap/2025#OtherLongTermInvestments http://fasb.org/us-gaap/2025#OtherLongTermInvestments http://fasb.org/us-gaap/2025#OtherLongTermInvestments http://fasb.org/us-gaap/2025#OtherLongTermInvestments http://fasb.org/us-gaap/2025#OtherLongTermInvestments…
• GL (GLOBE LIFE INC.)
• FY2025 10-K: …were employees, not independent contractors, of Globe Life Inc. and/or American Income Life Insurance Company and were discriminated against on the basis of sex, and that one complainant was also discriminated against on the basis of race. In addition, the EEOC asserts that there is reasonable cause to believe that a…
• FY2025 10-K: …2024-12-31 0000320335 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2024-12-31 0000320335 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2025-01-01 2025-12-31 0000320335 us-gaap:AociLiabilityForFuturePolicyBenefitParentMember 2025-01-01 2025-12-31 0000320335…
• CNO (CNO Financial Group, Inc.)
• FY2025 10-K: …capital requirements described below can also limit, in certain circumstances, the ability of our insurance subsidiaries to pay dividends. In accordance with an order from the Florida Office of Insurance Regulation, Washington National Insurance Company ("Washington National") may not distribute funds to any…
• FY2025 10-K: …Agents, insurance brokers and marketing companies who market our products and prospective purchasers of our products use the financial strength ratings of our insurance subsidiaries as an important factor in determining whether to market or purchase. Ratings have the biggest impact on our sales of supplemental health…
• PRI (Primerica, Inc.)
• FY2025 10-K: Funds (U.S.) Equitable Distributors, LLC (U.S.) Nuveen, LLC (U.S.) VOYA Financial, Inc. (U.S.) Fidelity Investments (U.S.) Franklin Templeton Investments (U.S.) Invesco (U.S.) AGF Investments (Canada) Mackenzie Investments (Canada) Other fund companies and plan administrator providers Managed Investments PFS…
• FY2025 10-K: …or "independent sales force"). We assist our clients in meeting their needs for term life insurance, which we underwrite, and mutual funds, annuities, managed investments and other financial products, which we distribute primarily on behalf of third parties. Our primary subsidiaries include the following entities:…
• MET (MetLife, Inc.)
• FY2025 10-K: …10-K, the Company uses certain abbreviations, acronyms and terms which are further detailed below. A.M. Best A.M. Best Company, Inc. Credit Facility Unsecured revolving credit facility ABO Accumulated Benefit Obligations CRO Chief Risk Officer ABS & CLO Asset-Backed Securities and Collateralized Loan Obligations…
• FY2025 10-K: …11, 2014 10.12.1 Form of Stock Option Agreement (Ratable Exercisability in Thirds) under the 2015 SIC Plan, effective January 1, 2015.* 8-K 001-15787 10.7 December 11, 2014 10.12.2 Form of Stock Option Agreement (Three-Year "Cliff" Exercisability) under the 2015 SIC Plan, effective January 1, 2015.* 8-K 001-15787…

Methodology Note

• Priced-in inversion: the valuation is inverted on the current price to recover the operating-income growth, duration, and steady-state margin the price embeds (ROE for financials, FFO growth for REITs).
• Valuation x-ray: the valuation models, grouped into four families (asset, earnings, relative, growth). Each model is expressed as a price/FV ratio (distance from price), not a point fair-value estimate. The spread across families is the disagreement.
• Economic-unit decomposition (SOTP): each disclosed business unit is assigned its native valuation basis before any multiple is applied. Operating units are valued on enterprise value; funded financial units are valued on their own common equity, because their borrowings fund earning assets rather than levering the parent. A company total is stated only once every material unit carries a supported value and the parent capital bridge reconciles.
• Solvency: net cash/debt, net-debt-to-NOPAT, interest coverage, and share-count CAGR from EDGAR financials (net debt / FFO and fixed-charge coverage for REITs; regulatory-capital framing for financials).
• Peer cohorts: per-segment comparables with deep-linkable SEC filing citations.

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.